[1] 陆再英, 谢毅, 钟南山, 等.内科学[M].7版.北京:人民卫生出版社, 2009:848-850.
[2] Barton GM, KaganJC.A cell biological view of Toll-like receptor function:regulation through compart mentalization[J].Nat Rev Immunol, 2009, 9(8):535-542.
[3] Korczowska I.Rheumatoid arthritis susceptibility genes:an overview[J].World J Orthop, 2014, 5(4):544-549.
[4] Litvack ML, Palaniyar N.Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components:implications on exacerbating or resolving inflammation[J].Innate Immun, 2010, 16(3):191-200.
[5] Aletaha D, Neogi T, Sliman AJ, et al.2010Rheumatology/European League Against Rheumatism Collaborative initiative[J].Ann Rheum Dis, 2010, 69(9):2569-2581.
[6] 马铃.静脉麻醉药物对脂多糖诱导的急性肺损伤大鼠肺组织CD1和TLR4受体的影响[D].沈阳:中国医科大学, 2010.
[7] Lin IC, Kuo HC, Lin YJ, et al.Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis[J].PLoS One, 2012, 7(6):e38635.
[8] Coulthard LR, Geiler J, Mathews RJ, et al.Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients[J].Clin Exp Immunol, 2012, 170(1):36-46.
[9] Ge XL, Li CR, Yang J, et al.Aberrantly decreased levels of NKG2D expression in children with kawasaki disease[J].Scand J Immunol, 2013, 77(5):389-397.
[10] Rossol M, Kraus S, Pierer M, et al.The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population[J].Arthritis Rheum, 2012, 64(3):671-677.
[11] Coulthard LR, Geiler J, Mathews RJ, et al.Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients[J].Clin Exp Immunol, 2012, 170(1):36-46.
[12] 张东霞, 赵龙凤, 郭伟民, 等.干燥综合征患者外周血淋巴细胞Toll样受体4CD14的表达[J].中国药物与临床, 2013(1):45-47.
[13] Mikuls TR, LeVan TD, Sayles H, et al.Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis[J].J Rheumatol, 2011, 38(12):2509-2516.